Biography & Research:
Anthony White obtained a PhD in neuroscience from Murdoch University in 1996, then undertook a post-doctoral position at University of Melbourne investigating Alzheimer’s and prion diseases. He then worked at Imperial College of Medicine, UK, in 2001 studying immunotherapeutic approaches to prion diseases. He obtained an RD Wright Fellowship (2004-2008) and established a research group at the Department of Pathology, University of Melbourne investigating the role of biometals in neurodegeneration and development of metal-based drugs for treatment of these disorders. He received an ARC Future Fellowship in 2011, was recruited to QIMR Berghofer in 2016, and is currently an NHMRC Senior Research Fellow. His research has led to the development of first-in-class metal-drugs as a potential new therapeutic approach to treat motor neuron disease. He is currently developing new human patient-based models of neurodegeneration including microglia, 3D cultures, and organoids to improve translational outcomes for neurotherapeutics.